<strong>Annual</strong> <strong>Report</strong> Year Ended December 31, 2014On November 17 th , Allergan announced a merger with Actavis plc for cash and stock valued at ~$240 pershare when the transaction closed on March 17 th . Prior to closing, we hedged a substantial portion of theActavis shares we would have received while electing to retain 1.35 million shares (held across all funds,~500,000 are held in <strong>PSH</strong>) in the newly merged company which we consider to be undervalued and wellmanaged.Herbalife Ltd. (HLF) ShortWe remain confident in our short thesis that HLF is an illegal pyramid scheme that will collapse orotherwise be shut down by regulators. The company’s business has continued to deteriorate as reflectedby its substantially reduced forward earnings guidance for 2015.Herbalife is doing its best to attack the messenger with a public relations campaign against PershingSquare. Ultimately, the facts will drive the outcome. We expect continued substantial businessdeterioration as the company is forced to reform its highly abusive and deceptive practices, or is shut down.Air Products and Chemicals, Inc. (APD)Air Products and Chemicals, Inc. has made meaningful progress since Seifi Ghasemi became CEO onJuly 1 st of 2014. We believe that Seifi is the ideal leader to transform Air Products, and we applaud the AirProducts Board for hiring Seifi as Chairman/CEO and supporting him in his efforts to improve thecompany.Seifi’s announced goals are to increase EBIT margins from ~16% to ~22.5%, comparable to that ofindustry leader Praxair Inc. Air Products expects that half of this 650 basis point improvement will comefrom SG&A and overhead, and half from gains in productivity and operational efficiencies. Air Productswas at the top of the industry two decades ago, and Seifi has stated that he believes there are nostructural issues that should prevent the company from regaining its industry-leading performance.Early results, including earnings announcements in October 2014 and January 2015, have beenimpressive. Earnings per share (EPS) have increased 13% and 16%, respectively in Seifi’s first twoquarters as CEO. Operating margins are at the highest levels in nearly a decade, driven partially byreductions in SG&A of ~8% in the most recent quarter. With operating margins now at ~17.5%, AirProducts has closed 150 basis points of its margin gap versus Praxair with remarkable rapidity. AirProducts’ fiscal year 2015 guidance calls for EPS of $6.30-6.55, which represents growth of 10-13%despite foreign exchange headwinds.Canadian Pacific Railway Limited (CP)The remarkable transformation of Canadian Pacific continues under the leadership of Hunter Harrisonand the reconstituted CP Board in 2014. Full-year EPS grew 32%, in spite of severe winter weatherconditions in the first quarter of the year. In 2014, CP achieved an operating ratio of 64.7%, besting itsfour-year 65% operating ratio target just two years into the operating plan. On an annual basis, CP hasrisen from the least efficient Class I railroad to the third-best, and the improvements are continuing. Thisprogress has been achieved while maintaining industry-leading safety performance. The drive tooperational excellence is enhancing service and reliability, while lowering CP’s cost to serve itscustomers.In October, CP held an analyst day to outline its revised multi-year plan. The company’s new four-yeartargets call for $10 billion of revenue by 2018, representing a 10.5% compound annual growth rate. Thisimpressive revenue growth is driven by efficiencies and service-level improvements that permit CP to winbusiness for which it historically could not compete.CP’s announced revenue and margin goals translate into about $20 per share in earnings in 2018including the impact of projected share repurchases. At the inception of our investment in 2011, CPearned $3.15 per share. The achievement of $20 per share in earnings would represent more than a sixfoldincrease in the earnings power of the business following the proxy contest and Hunter Harrison’sappointment as CEO. We believe CP remains an attractive investment led by a superlative managementteam.6 PERSHING SQUARE HOLDINGS, LTD.
<strong>Annual</strong> <strong>Report</strong> Year Ended December 31, 2014Restaurant Brands International Inc. (RBI)At the end of August, Burger King announced that it would acquire Tim Hortons, Canada’s leading quickservicerestaurant (QSR) company, for $12 billion forming the newly renamed Restaurant BrandsInternational (RBI). The transaction closed in December of 2014. Tim Hortons operates a 100%franchised business model with ~4,500 units. In Canada, where 80% of Tim Hortons’ restaurants arelocated, the company commands a market share which RBI estimates to be more than 40% of total QSRtraffic and nearly 75% of QSR caffeinated beverages sales.We believe the acquisition of Tim Hortons will create significant long-term value for RBI shareholders asexecuted by the company’s controlling shareholder, 3G Capital, which has an extremely strong trackrecord of successful business transformations. In the four years that 3G has owned a controlling stake inRBI, the company has dramatically improved its operations, reduced its capital intensity, significantlygrown its number of restaurants, and put in place an improved capital structure.We believe the improvements that 3G has enacted at Burger King will serve as a template to create valuein the Tim Hortons transaction. We believe there is substantial unit growth opportunity outside of Canada,and that under 3G’s leadership, Tim Hortons is well positioned to identify meaningful operations andcapital efficiencies. The acquisition enhances Restaurant Brands’ medium and long-term EPS growthrate, and long-term shareholder value.Platform Specialty Products Corporation (PAH)We believe that Platform Specialty Products has the opportunity to invest large amounts of capital at ahigh rate of return by acquiring a portfolio of specialty chemicals businesses that can operate moreefficiently as part of a larger industry platform.Platform’s business model of investment in asset-light, high-touch specialty chemical businesses ischaracterized by high margins, low capital intensity, and high switching-costs. Platform’s managementteam has a demonstrated record of value creation which benefits by an environment which is favorablefor M&A activity.In 2014, the company announced $5 billion in acquisitions in the agricultural chemicals industry byacquiring Chemtura AgroSolutions, Agriphar and Arysta LifeScience Limited. Agricultural chemicals arevital to increased food production, and are a key input to growing crop output to meet the rising demandfor food worldwide. Agricultural chemicals have high barriers to entry, both from the need for intensive(and lengthy) research programs and the high hurdle of regulatory approval associated with any input inthe food chain. With these acquisitions, we believe that Platform has assembled a leading global cropsolutions business that offers a full product portfolio and diversity across crop varieties and geographies.Zoetis Inc. (ZTS)In November, Pershing Square announced an 8.5% stake in Zoetis, the world leader in branded animalhealthcare products. Until 2013, Zoetis was a non-core subsidiary of Pfizer, whose primary business ishuman healthcare products. In January 2013, Pfizer completed an initial public offering of a 20% stake inZoetis. The separation from Pfizer was completed in June 2013, when Pfizer split off its remaining 80%ownership to its shareholders.The separation resulted in the creation of the only large, independent, publicly traded animal healthcompany in the world. The company has a market capitalization of ~$24 billion and ~$5 billion in revenue.Zoetis’ business model passes our high bar for business quality. Zoetis participates in markets with strongsecular growth, driven by global increases in protein consumption, pet ownership, and the use ofmedicines to treat pets and livestock. As a result, the global animal health market has grown at anaverage of about 4% since 2008 and has experienced positive volume growth every year since 2003.Historically, Zoetis’ organic growth has exceeded the industry average.PERSHING SQUARE HOLDINGS, LTD. 7
- Page 1 and 2: 2014 Annual Report
- Page 3 and 4: Annual Report Year Ended December 3
- Page 5 and 6: Annual Report Year Ended December 3
- Page 7: Annual Report Year Ended December 3
- Page 11 and 12: Annual Report Year Ended December 3
- Page 13 and 14: Annual Report Year Ended December 3
- Page 15 and 16: Annual Report Year Ended December 3
- Page 17 and 18: Annual Report Year Ended December 3
- Page 19 and 20: Annual Report Year Ended December 3
- Page 21 and 22: Annual Report Year Ended December 3
- Page 23 and 24: Annual Report Year Ended December 3
- Page 25 and 26: Annual Report Year Ended December 3
- Page 27 and 28: Annual Report Year Ended December 3
- Page 29 and 30: Annual Report Year Ended December 3
- Page 31 and 32: Annual Report Year Ended December 3
- Page 33 and 34: Annual Report Year Ended December 3
- Page 35 and 36: Annual Report Year Ended December 3
- Page 37 and 38: Annual Report Year Ended December 3
- Page 39 and 40: Annual Report Year Ended December 3
- Page 41 and 42: Annual Report December 31, 2014Stat
- Page 43 and 44: Annual Report Years Ended December
- Page 45 and 46: Annual Report Years Ended December
- Page 47 and 48: Annual Report December 31, 2014Note
- Page 49 and 50: Annual Report December 31, 2014Note
- Page 51 and 52: Annual Report December 31, 2014Note
- Page 53 and 54: Annual Report December 31, 2014Note
- Page 55 and 56: Annual Report December 31, 2014Note
- Page 57 and 58: Annual Report December 31, 2014Note
- Page 59 and 60:
Annual Report December 31, 2014Note
- Page 61 and 62:
Annual Report December 31, 2014Note
- Page 63 and 64:
Annual Report December 31, 2014Note
- Page 65 and 66:
Annual Report December 31, 2014Note
- Page 67 and 68:
Annual Report December 31, 2014Note
- Page 69 and 70:
Annual Report December 31, 2014Note
- Page 71 and 72:
Annual Report December 31, 2014Note
- Page 73 and 74:
Annual Report December 31, 2014U.S.
- Page 75 and 76:
Annual Report Year Ended December 3
- Page 77 and 78:
Annual Report Year Ended December 3